Free to read · nothing for sale · no ads, no sponsors · funded by donation

Open Source Apothecary At Home

Open Source Apothecary At Home / Brain and nerves

Restless legs syndrome

Iron status is the most treatable cause and the most commonly missed. This is one of the few places a ferritin really matters.

remedy

Restless legs syndrome is an urge to move the legs, worse at rest and in the evening, relieved by movement. It is common, it disrupts sleep badly, and it has a treatable cause that is routinely missed.

Iron status is the key. Brain iron insufficiency is central to restless legs syndrome, and a ferritin below about 75 mcg/L is generally treated even if the haemoglobin is normal — the threshold is higher than the usual definition of iron deficiency. Iron supplementation in that setting improves symptoms substantially in many people. This is a blood test and it is the highest-value action on the page, and it is commonly not done because the haemoglobin is normal.

Medication review. Several common drugs worsen restless legs: sedating antihistamines (diphenhydramine, and many over-the-counter sleep aids), most antidepressants, dopamine antagonist antiemetics (metoclopramide, prochlorperazine), and some antihypertensives. A person with restless legs taking an antihistamine at night for sleep is making it worse — this is one of the most useful things to know on this page and it is very commonly missed.

Other causes to exclude. Iron deficiency, kidney disease, diabetes and peripheral neuropathy, pregnancy (restless legs is common and usually resolves), and low ferritin generally.

What helps. Iron supplementation if the ferritin is low; correcting the cause; gentle exercise and stretching in the evening; reducing caffeine and alcohol in the evening; a warm bath before bed; and, if symptoms are still troublesome, prescription treatment — dopamine agonists (which carry an augmentation risk with long-term use), alpha-2-delta ligands (gabapentin, pregabalin), or others, decided by a clinician.

Magnesium is commonly recommended, and the trials are weak. Given that magnesium supplementation is genuinely dangerous in kidney impairment, and that kidney disease is a cause of restless legs, check kidney function first.

Cramp and restless legs are different. Cramp is a painful muscle contraction; restless legs is an urge to move. For cramp, see the cramps page — and the same lesson applies: magnesium is the folk answer and the trials did not support it.

What the studies found

Meta-Analysis2024Journal of pineal research

Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose-Response Meta-Analysis.

Our results suggest that advancing the timing of administration (3 h before the desired bedtime) and increasing the administered dose (4 mg/day), as compared to the exogenous melatonin schedule most used in clinical practice (2 mg 30 min before the desired bedtime), might optimize the efficacy of exogenous melatonin in promoting sleep.
PubMed 38888087 ↗
Meta-Analysis2024Journal of diabetes and its complications

Disease-modifying therapies for diabetic peripheral neuropathy: A systematic review and meta-analysis of randomized controlled trials.

For diabetic peripheral neuropathy, the triple-combination therapy may be more effective than monotherapy or dual therapy.
PubMed 38330524 ↗
Meta-Analysis2024Pharmaceutical biology

Comparative efficacy and safety of Chinese patent medicines as an adjunctive therapy for diabetic peripheral neuropathy: systematic review and network meta-analysis of randomized controlled trials.

This network meta-analysis confirms the efficacy and safety of 37 CPMs combined with Mec or αLA for treating DPN.
PubMed 39497372 ↗
Meta-Analysis2023Sleep medicine reviews

Efficacy and tolerability of pharmacological treatments for insomnia in adults: A systematic review and network meta-analysis.

These findings should aid clinicians in matching risk/benefits of drugs available in their countries to insomnia symptoms.
PubMed 36701954 ↗

Preparation

The first action

  • Get the ferritin checked. A level below about 75 mcg/L is generally treated even with a normal haemoglobin.
  • Also check kidney function, glucose and B12
  • Review the medicine list for drugs that worsen it

Iron if the ferritin is low

  • Take it as described on the iron page: alternate-day dosing is at least as effective, with vitamin C, away from tea, coffee and calcium
  • Recheck the ferritin after 8-12 weeks
  • Oral iron may not raise brain iron effectively in everyone; some people need intravenous iron, which is a clinician's decision

Drugs that worsen restless legs

  • Sedating antihistamines — diphenhydramine and many over-the-counter sleep aids
  • Most antidepressants, particularly SSRIs and mirtazapine
  • Dopamine antagonist antiemetics — metoclopramide, prochlorperazine, promethazine
  • Some antihypertensives
  • If you take an antihistamine at night for sleep and have restless legs, this is likely making it worse. Ask for an alternative.

Measures that help

  • Gentle evening exercise and stretching; a walk after dinner
  • A warm bath before bed
  • Reduce caffeine and alcohol in the evening
  • Distraction and activity when symptoms start; lying still makes it worse
  • Consistent sleep timing

Prescription treatment if needed

  • Dopamine agonists (with an augmentation risk on long-term use), or alpha-2-delta ligands (gabapentin, pregabalin)
  • Iron infusion where oral iron fails and the ferritin is low
  • This is a clinician's decision, and augmentation is a specific reason to keep the follow-up

Magnesium

  • Trials are weak
  • Do not use magnesium if kidney function is reduced — and kidney disease is a cause of restless legs, so check first

Cautions and interactions

When this is not a self-care problem — get help

Related

Sources

  1. Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose-Response Meta-Analysis. Journal of pineal research 2024; doi:10.1111/jpi.12985 PubMed 38888087
  2. Disease-modifying therapies for diabetic peripheral neuropathy: A systematic review and meta-analysis of randomized controlled trials. Journal of diabetes and its complications 2024; doi:10.1016/j.jdiacomp.2024.108691 PubMed 38330524
  3. Comparative efficacy and safety of Chinese patent medicines as an adjunctive therapy for diabetic peripheral neuropathy: systematic review and network meta-analysis of randomized controlled trials. Pharmaceutical biology 2024; doi:10.1016/j.jep.2024.118355 PubMed 39497372
  4. Efficacy and tolerability of pharmacological treatments for insomnia in adults: A systematic review and network meta-analysis. Sleep medicine reviews 2023; doi:10.1016/j.smrv.2023.101746 PubMed 36701954